Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -9.15%-1.26B | 82.62%-216M | 62.63%-417M | -19.17%-4.3B | 47.98%-785M | -19.38%-1.16B | -11.78%-1.24B | -5,773.68%-1.12B | -116.43%-3.61B | -140.67%-1.51B |
| Net profit before non-cash adjustment | 18.18%351M | -51.95%160M | -45.38%195M | -33.92%1.12B | -77.72%133M | -15.86%297M | -25.84%333M | 20.61%357M | 98.25%1.7B | 273.13%597M |
| Total adjustment of non-cash items | 187.26%226M | 15.24%242M | -48.57%90M | -130.08%-306M | -23.08%-432M | -423.75%-259M | 496.23%210M | -8.38%175M | -120.18%-133M | -225.81%-351M |
| -Depreciation and amortization | 12.50%99M | 3.16%98M | 0.00%93M | 16.33%399M | 30.85%123M | 2.33%88M | 13.10%95M | 17.72%93M | 3.00%343M | 18.99%94M |
| -Reversal of impairment losses recognized in profit and loss | 1,618.75%275M | ---- | ---- | -212.90%-35M | -150.00%-15M | -56.76%16M | ---- | ---- | -73.95%31M | -105.13%-6M |
| -Share of associates | -1,200.00%-52M | -1,300.00%-56M | -6,300.00%-64M | 595.24%104M | 1,041.67%113M | 20.00%-4M | 50.00%-4M | -125.00%-1M | -187.50%-21M | -209.09%-12M |
| -Disposal profit | 95.94%-8M | 175.00%11M | --4M | -78,500.00%-786M | ---593M | -19,600.00%-197M | --4M | --0 | 96.67%-1M | --0 |
| -Net exchange gains and losses | -96.15%1M | -142.86%-3M | 150.00%15M | 186.57%58M | 170.37%19M | 85.71%26M | 112.07%7M | 50.00%6M | -226.42%-67M | -142.86%-27M |
| -Remuneration paid in stock | ---2M | 0.00%2M | 100.00%2M | 0.00%5M | 0.00%2M | --0 | 100.00%2M | 0.00%1M | 162.50%5M | 107.14%2M |
| -Other non-cash items | 53.72%-87M | 30.28%185M | -47.37%40M | 87.94%-51M | 79.85%-81M | -261.54%-188M | 297.22%142M | -26.21%76M | -351.79%-423M | -700.00%-402M |
| Changes in working capital | -53.97%-1.84B | 65.36%-619M | 57.40%-702M | 1.08%-5.12B | 72.31%-486M | 14.83%-1.2B | -18.50%-1.79B | -225.69%-1.65B | -62.54%-5.17B | -64.63%-1.76B |
| -Change in receivables | -609.52%-321M | 621.05%396M | -742.31%-167M | -90.91%35M | 540.00%22M | -30.77%63M | -125.59%-76M | 1,200.00%26M | 201.05%385M | -100.20%-5M |
| -Change in inventory | 394.12%100M | -566.67%-40M | ---22M | 33.33%-32M | 120.00%8M | -277.78%-34M | -400.00%-6M | --0 | -92.00%-48M | -290.48%-40M |
| -Change in payables | 66.80%-166M | -57.43%-477M | 52.85%-182M | -309.16%-1.42B | 21.18%-227M | -310.97%-500M | -694.12%-303M | -157.02%-386M | 102.09%677M | 40.98%-288M |
| -Changes in other current assets | -100.69%-1.45B | 64.48%-498M | 74.30%-331M | 40.14%-3.7B | 79.68%-289M | 57.96%-724M | 24.54%-1.4B | -8.78%-1.29B | -98.84%-6.19B | 54.04%-1.42B |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -2,425.00%-101M | -300.00%-32M | -33.33%-4M | -200.00%-24M | -200.00%-9M | -100.00%-4M | -300.00%-8M | -200.00%-3M | -60.00%-8M | -200.00%-3M |
| Interest received (cash flow from operating activities) | -11.43%31M | -156.67%-17M | 148.00%62M | 38.38%137M | 56.67%47M | 12.90%35M | 50.00%30M | 38.89%25M | 16.47%99M | -25.00%30M |
| Tax refund paid | 9.20%-79M | 52.38%-80M | 17.02%-39M | -38.33%-332M | 40.00%-30M | -45.00%-87M | -97.65%-168M | -4.44%-47M | -84.62%-240M | -66.67%-50M |
| Other operating cash inflow (outflow) | 23.73%391M | -14.11%274M | -19.72%285M | 62.63%1.51B | 74.92%516M | -0.63%316M | 46.33%319M | 273.68%355M | 87.83%926M | 95.36%295M |
| Operating cash flow | -13.81%-1.02B | 93.36%-71M | 85.62%-113M | -6.42%-3.02B | 78.90%-261M | -31.48%-898M | -11.34%-1.07B | -1,737.50%-786M | -131.27%-2.83B | -164.88%-1.24B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -1,268.75%-438M | 22.11%-74M | 50.00%-50M | -26.27%-298M | 39.83%-71M | -39.13%-32M | -115.91%-95M | -96.08%-100M | 76.23%-236M | 51.44%-118M |
| Net intangibles purchase and sale | -980.00%-54M | -2,800.00%-29M | ---137M | 57.14%-3M | 250.00%3M | -150.00%-5M | ---1M | --0 | -75.00%-7M | 50.00%-2M |
| Net business purchase and sale | 0.00%-1M | 400.00%3M | ---3M | -714.81%-220M | -1,262.50%-218M | 90.91%-1M | 75.00%-1M | --0 | -125.00%-27M | -245.45%-16M |
| Net investment product transactions | -425.71%-114M | -69.54%46M | 105.68%10M | -28.00%36M | -87.00%26M | 116.36%35M | 343.55%151M | -239.68%-176M | 169.44%50M | 500.00%200M |
| Advance cash and loans provided to other parties | -166.67%-6M | 77.27%-5M | 75.00%-3M | 37.50%-35M | 64.29%-10M | 250.00%9M | -10.00%-22M | -500.00%-12M | -522.22%-56M | ---28M |
| Dividends received (cash flow from investment activities) | --63M | -108.70%-2M | --95M | -2.86%34M | --11M | --0 | 27.78%23M | --0 | -28.57%35M | --0 |
| Investing cash flow | -7,816.67%-463M | -210.91%-61M | 69.44%-88M | -101.66%-486M | -819.44%-259M | 102.34%6M | 149.11%55M | -416.48%-288M | 76.85%-241M | 112.59%36M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -36.26%348M | -76.24%816M | 1,628.89%778M | -9.36%5B | -48.10%971M | -80.33%546M | 808.47%3.43B | -90.76%45M | 725.15%5.51B | 1,585.59%1.87B |
| Net common stock issuance | 105.88%8M | 406.12%300M | -186.83%-244M | 3,035.29%533M | --486M | ---136M | ---98M | 1,552.94%281M | -98.30%17M | --0 |
| Net preferred stock issuance | --22M | ---- | ---- | --60M | --60M | --0 | ---- | ---- | --0 | ---- |
| Increase or decrease of lease financing | 8.33%-11M | 37.50%-5M | -12.50%-9M | -42.11%-54M | -36.84%-26M | -100.00%-12M | -14.29%-8M | -33.33%-8M | -65.22%-38M | -72.73%-19M |
| Cash dividends paid | ---81M | ---20M | ---28M | 56.32%-38M | 58.62%-24M | ---- | ---- | ---- | 0.00%-87M | -100.00%-58M |
| Cash dividends for minorities | 89.57%-12M | -10.00%-11M | 43.33%-17M | -302.22%-181M | ---26M | -538.89%-115M | ---10M | -11.11%-30M | 35.71%-45M | --0 |
| Interest paid (cash flow from financing activities) | 9.68%-280M | 6.53%-272M | -26.07%-382M | -72.04%-1.34B | -87.39%-431M | -38.39%-310M | -56.45%-291M | -122.79%-303M | -68.33%-776M | -52.32%-230M |
| Net other fund-raising expenses | -146.58%-34M | 58.77%-47M | -156.25%-27M | -338.10%-644M | -1,128.30%-651M | 370.37%73M | -147.83%-114M | 328.57%48M | 40.73%-147M | -116.31%-53M |
| Financing cash flow | -225.00%-40M | -32.58%1.96B | 115.15%71M | -24.77%3.34B | -76.24%359M | -98.71%32M | 1,995.68%2.91B | -89.49%33M | 467.99%4.44B | 537.55%1.51B |
| Net cash flow | ||||||||||
| Beginning cash position | 11.50%4.17B | 24.13%2.42B | -12.74%2.59B | 108.72%2.97B | 0.33%2.76B | 240.31%3.74B | 0.67%1.95B | 108.72%2.97B | -48.76%1.42B | 33.40%2.75B |
| Current changes in cash | -77.33%-1.53B | -3.48%1.83B | 87.51%-130M | -112.04%-164M | -151.94%-161M | -156.10%-860M | 303.21%1.9B | -329.80%-1.04B | 191.72%1.36B | 160.08%310M |
| Effect of exchange rate changes | 103.03%4M | 24.53%-80M | -300.00%-42M | -216.30%-214M | 103.33%3M | -213.79%-132M | -208.16%-106M | -65.00%21M | 39.39%184M | 26.23%-90M |
| End cash Position | -3.92%2.65B | 11.50%4.17B | 24.13%2.42B | -12.74%2.59B | -12.74%2.59B | 0.33%2.76B | 240.31%3.74B | 0.67%1.95B | 108.72%2.97B | 108.72%2.97B |
| Free cash flow | -61.93%-1.51B | 85.08%-174M | 66.14%-300M | -7.73%-3.32B | 75.76%-329M | -31.69%-935M | -16.02%-1.17B | -14,666.67%-886M | -31.31%-3.08B | -84.38%-1.36B |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.